|
1
|
Kofoed H, Kamby C and Anagnostaki L:
Aggressive fibromatosis. Surg Gynecol Obstet. 160:124–127.
1985.PubMed/NCBI
|
|
2
|
Rock MG, Pritchard DJ, Reiman HM, Soule EH
and Brewster RC: Extra-abdominal desmoid tumors. J Bone Joint Surg
Am Vol. 66:1369–1374. 1984. View Article : Google Scholar
|
|
3
|
Michael J, Kaplan, Britt-Marie, Ljung,
Enzinger FM and Weiss SW: Soft Tissue Tumors (1983) C.V. Mosby Co.,
St Louis. American Journal of Otolaryngology. 1985.
|
|
4
|
Mackenzie HD: The fibromatoses: A
clinicopathological concept. Br Med J. 4:277–281. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Musgrove JE and Mcdonald JR:
Extra-abdominal desmoid tumors; their differential diagnosis and
treatment. Arch Pathol (Chic). 45:513–540. 1948.PubMed/NCBI
|
|
6
|
Li Destri G, Ferraro MJ, Calabrini M,
Pennisi M and Magro G: Desmoid-type fibromatosis of the mesentery:
Report of a sporadic case with emphasis on differential diagnostic
problems. Case Rep Med. 2014:850180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martínez Trufero J, Pajares Bernad I,
Torres Ramón I, Hernando Cubero J and Pazo Cid R: Desmoid-type
fibromatosis: Who, when, and how to treat. Curr Treat Options
Oncol. 18:292017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Escobar C, Munker R, Thomas JO, Li BD and
Burton GV: Update on desmoid tumors. Ann Oncol. 23:562–569. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nieuwenhuis MH, Lefevre JH, Bülow S,
Järvinen H, Bertario L, Kernéis S, Parc Y and Vasen HF: Family
history, surgery, and APC mutation are risk factors for desmoid
tumors in familial adenomatous polyposis: An international cohort
study. Dis Colon Rectum. 54:1229–1234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amary MF, Pauwels P, Meulemans E, Roemen
GM, Islam L, Idowu B, Bousdras K, Diss TC, O'Donnell P and Flanagan
AM: Detection of beta-catenin mutations in paraffin-embedded
sporadic desmoid-type fibromatosis by mutation-specific restriction
enzyme digestion (MSRED): An ancillary diagnostic tool. Am J Surg
Pathol. 31:1299–1309. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rhim JH, Kim JH, Moon KC, Park SW, Sohn
CH, Choi SH, Yun TJ and Chang KH: Desmoid-type fibromatosis in the
head and neck: CT and MR imaging characteristics. Neuroradiology.
55:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murphey MD, Ruble CM, Tyszko SM,
Zbojniewicz AM, Potter BK and Miettinen M: From the archives of the
AFIP: Musculoskeletal fibromatoses: Radiologic-pathologic
correlation. Radiographics. 29:2143–2173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sinha A, Hansmann A, Bhandari S, Gupta A,
Burling D, Rana S, Phillips RK, Clark SK and Goh V: Imaging
assessment of desmoid tumours in familial adenomatous polyposis: Is
state-of-the-art 1.5 T MRI better than 64-MDCT? Br J Radiol.
85:e254–e261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dinauer PA, Brixey CJ, Moncur JT,
Fanburg-Smith JC and Murphey MD: Pathologic and MR imaging features
of benign fibrous soft-tissue tumors in adults. Radiographics.
27:173–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robbin MR, Murphey MD, Temple HT,
Kransdorf MJ and Choi JJ: Imaging of musculoskeletal fibromatosis.
Radiographics. 21:585–600. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salas S, Dufresne A, Bui B, Blay JY,
Terrier P, Ranchere-Vince D, Bonvalot S, Stoeckle E, Guillou L, Le
Cesne A, et al: Prognostic factors influencing Progression-free
survival determined from a series of sporadic desmoid tumors: A
Wait-and-See policy according to tumor presentation. J Clin Oncol.
29:3553–3558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gari MK, Guraya SY, Hussein AM and Hego
MM: Giant mesenteric fibromatosis: Report of a case and review of
the literature. World J Gastrointest Surg. 4:79–82. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ogawa T: Complete resection of a rectus
abdominis muscle invaded by desmoid tumors and subsequent
management with an abdominal binder: A case report. J Med Case
Reps. 12:292018. View Article : Google Scholar
|
|
19
|
Okamura S, Kitahara T, Tamai K, Minoji T,
Takabatake H, Watanabe N, Yamamura N, Fukuchi N, Ebisui C, Yokouchi
H, et al: Resection of a desmoid tumor originating from the greater
omentum after surgery for colon cancer and liver metastasis-a case
report. Gan To Kagaku Ryoho. 45:2444–2446. 2018.(In Japanese).
PubMed/NCBI
|
|
20
|
Howard JH and Pollock RE: Intra-abdominal
and abdominal wall desmoid fibromatosis. Oncol Ther. 4:57–72. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng PD, Hyder O, Mavros MN, Turley R,
Groeschl R, Firoozmand A, Lidsky M, Herman JM, Choti M, Ahuja N, et
al: Management and recurrence patterns of desmoids tumors: A
Multi-institutional analysis of 211 patients. Ann Surg Oncol.
19:4036–4042. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsagozis P, Stevenson JD, Grimer R and
Carter S: Outcome of surgery for primary and recurrent desmoid-type
fibromatosis. A retrospective case series of 174 patients. Ann Med
Surg (Lond). 7:14–19. 2017. View Article : Google Scholar
|
|
23
|
Janssen ML, Van Broekhoven DL, Cates JM,
Bramer WM, Nuyttens JJ, Gronchi A, Salas S, Bonvalot S, Grünhagen
DJ and Verhoef C: Meta-analysis of the influence of surgical margin
and adjuvant radiotherapy on local recurrence after resection of
sporadic desmoid-type fibromatosis. Br J Surg. 104:347–357. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kujak JL, Liu PT, Johnson GB and Callstrom
MR: Early experience with percutaneous cryoablation of
extra-abdominal desmoid tumors. Skeletal Radiol. 39:175–182. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leithner A, Gapp M, Leithner K, Radl R,
Krippl P, Beham A and Windhager R: Margins in extra-abdominal
desmoid tumors: A comparative analysis. J Surg Oncol. 86:152–156.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith K, Desai J, Lazarakis S and Gyorki
D: Systematic review of clinical outcomes following various
treatment options for patients with extraabdominal desmoid tumors.
Ann Surg Oncol. 25:1544–1554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lev D, Kotilingam D, Wei C, Ballo MT,
Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS and Pollock
RE: Optimizing treatment of desmoid tumors. J Clin Oncol.
25:1785–1791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gronchi A, Casali PG, Mariani L, Lo Vullo
S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M
and Rosai J: Quality of surgery and outcome in extra-abdominal
aggressive fibromatosis: A series of patients surgically treated at
a single institution. J Clin Oncol. 21:1390–1397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Merchant NB, Lewis JJ, Woodruff JM, Leung
DHY and Brennan MF: Extremity and trunk desmoid tumors: A
multifactorial analysis of outcome. Cancer. 86:2045–2052. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ballo MT, Zagars GK, Pollack A, Pisters
PWT and Pollock RA: Desmoid tumor: Prognostic factors and outcome
after surgery, radiation therapy, or combined surgery and radiation
therapy. J Clin Oncol. 17:158–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gronchi A, Le Péchoux C, Dei Tos AP, Le
Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali PG,
Stoeckle E, et al: Sporadic desmoid-type fibromatosis: A stepwise
approach to a non-metastasising neoplasm-A position paper from the
Italian and the French Sarcoma Group. Ann Oncol. 25:578–583. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cobianchi L, Ravetta V, Viera FT,
Filisetti C, Siri B, Segalini E, Maestri M, Dominioni T, Alessiani
M, Rossi S and Dionigi P: The challenge of extraabdominal desmoid
tumour management in patients with Gardner's syndrome:
Radiofrequency ablation, a promising option. World J Surg Oncol.
12:3612014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tremblay KR, Lea WB, Neilson JC, King DM
and Tutton SM: Percutaneous cryoablation for the treatment of
extra-abdominal desmoid tumors. J Surg Oncol. 120:366–375. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Knudsen AL and Bülow S: Desmoid tumour in
familial adenomatous polyposis. A review of literature. Fam Cancer.
1:111–119. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eastley N, McCulloch T, Esler C, Hennig I,
Fairbairn J, Gronchi A and Ashford R: Extra-abdominal desmoid
fibromatosis: A review of management, current guidance and
unanswered questions. Eur J Surg Oncol. 42:1071–1083. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Colombo C, Miceli R, Le Péchoux C,
Palassini E, Honoré C, Stacchiotti S, Mir O, Casali PG, Dômont J,
Fiore M, et al: Sporadic extra abdominal wall desmoid-type
fibromatosis: Surgical resection can be safely limited to a
minority of patients. Eur J Cancer. 51:186–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bonvalot S, Ternès N, Fiore M, Bitsakou G,
Colombo C, Honoré C, Marrari A, Le Cesne A, Perrone F, Dunant A and
Gronchi A: Spontaneous regression of primary abdominal wall desmoid
tumors: More common than previously thought. Ann Surg Oncol.
20:4096–4102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bonvalot S, Eldweny H, Haddad V, Rimareix
F, Missenard G, Oberlin O, Vanel D, Terrier P, Blay JY, Le Cesne A
and Le Péchoux C: Extra-abdominal primary fibromatosis: Aggressive
management could be avoided in a subgroup of patients. Eur J Surg
Oncol. 34:462–468. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cho JY, Gupta S, Cho HS, Park MS, Mok SJ,
Han I and Kim HS: Role of nonsteroidal anti-inflammatory drug in
treatment of extra-abdominal desmoid tumors. Clin Orthop Surg.
10:225–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao J, Wang Q, Li X, Hu X and Shen H:
Effective high intensity focused ultrasound treatment in recurrent
aggressive breast fibromatosis: A case report. Onco Targets Ther.
12:5251–5256. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
De Bree E, Zoras O, Hunt JL, Takes RP,
Suárez C, Mendenhall WM, Hinni ML, Rodrigo JP, Shaha AR, Rinaldo A,
et al: Desmoid tumors of the head and neck: A therapeutic
challenge. Head Neck. 36:1517–1526. 2014.PubMed/NCBI
|
|
42
|
Briand S, Barbier O, Biau D,
Bertrand-Vasseur A and Gouin F: Wait-and-See policy as a First-line
management for extra-abdominal desmoid tumors. J Bone Joint Surg
Am. 96:631–638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kamath SS, Parsons JT, Marcus RB, Zlotecki
RA and Scarborough MT: Radiotherapy for local control of aggressive
fibromatosis. Int J Radiat Oncol Biol Phys. 36:325–328. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Goy BW, Lee SP, Eilber F, Dorey F, Eckardt
J, Fu YS, Juillard GJ and Selch MT: The role of adjuvant
radiotherapy in the treatment of resectable desmoid tumors. Int J
Radiat Oncol Biol Phys. 39:659–665. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Boland PJ, Leung DH, Woodruff JM and
Brennan MF: The enigma of desmoid tumors. Ann Surg. 229:866–873.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guadagnolo BA, Zagars GK and Ballo MT:
Long-term outcomes for desmoid tumors treated with radiation
therapy. Int J Radiat Oncol Biol Phys. 71:441–447. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bishop AJ, Zarzour MA, Ratan R, Torres KE,
Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL and Guadagnolo BA:
Long-Term outcomes for patients with desmoid fibromatosis treated
with radiation therapy: A 10-Year Update and Re-evaluation of the
role of radiation therapy for younger patients. Int J Radiat Oncol
Biol Phys. 103:1167–1174. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen Y, Chen Y and Liu Y: Abnormal
presentation of aggressive fibromatosis after radiotherapy for
keloids case report and brief literature review. Ann Plast Surg.
83:104–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nuyttens JJ, Rust PF, Thomas CR Jr and
Turrisi AT III: Surgery versus radiation therapy for patients with
aggressive fibromatosis or desmoid tumors: A comparative review of
22 articles. Cancer. 88:1517–1523. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pritchard DJ, Nascimento AG and Petersen
IA: Local control of extra-abdominal desmoid tumors. J Bone Joint
Surg Am. 78:848–854. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Constantinidou A, Jones RL, Scurr M,
Al-Muderis O and Judson I: Advanced aggressive fibromatosis:
Effective palliation with chemotherapy. Acta Oncologica.
50:455–461. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sze H and Yeung MW: Fibromatosis of the
neck causing airway obstruction managed effectively with weekly
low-dose methotrexate and vinblastine. Hong Kong Med J. 15:221–223.
2009.PubMed/NCBI
|
|
53
|
Chaudhary P: Mesenteric fibromatosis. Int
J Colorectal Dis. 29:1445–1451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Skapek SX, Hawk BJ, Hoffer FA, Dahl GV,
Granowetter L, Gebhardt MC, Ferguson WS and Grier HE: Combination
chemotherapy using vinblastine and methotrexate for the treatment
of progressive desmoid tumor in children. J Clin Oncol.
16:3021–3027. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Janinis J, Patriki M, Vini L, Aravantinos
G and Whelan JS: The pharmacological treatment of aggressive
fibromatosis: A systematic review. Ann Oncol. 14:181–190. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kasper B: Systemic treatment approaches
for sporadic desmoid-type fibromatosis: Scarce evidence and
recommendations. Oncol Res Treat. 38:244–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Penel N, Le Cesne AL, Bonvalot S, Giraud
A, Bompas E, Rios M, Salas S, Isambert N, Boudou-Rouquette P,
Honore C, et al: Surgical versus non-surgical approach in primary
desmoid-type fibromatosis patients: A nationwide prospective cohort
from the French Sarcoma Group. Eur J Cancer. 83:125–131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kasper B, Gruenwald V, Reichardt P, Bauer
S, Rauch G, Limprecht R, Sommer M, Dimitrakopoulou-Strauss A, Pilz
L, Haller F and Hohenberger P: Imatinib induces sustained
progression arrest in RECIST progressive desmoid tumours: Final
results of a phase II study of the German Interdisciplinary Sarcoma
Group (GISG). Eur J Cancer. 76:60–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Penel N, Le Cesne AL, Bui BN, Perol D,
Brain EG, Ray-Coquard I, Guillemet C, Chevreau C, Cupissol D,
Chabaud S, et al: Imatinib for progressive and recurrent aggressive
fibromatosis (desmoid tumors): An FNCLCC/French Sarcoma Group phase
II trial with a long-term follow-up. Ann Oncol. 22:452–457. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chugh R, Wathen JK, Patel SR, Maki RG,
Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels
BL, et al: Efficacy of imatinib in aggressive fibromatosis: Results
of a phase II multicenter sarcoma alliance for research through
collaboration (SARC) trial. Clin Cancer Res. 16:4884–4891. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu LP, Ho RL, Chen GG and Lai PB:
Sorafenib inhibits hypoxia-inducible factor-1α synthesis:
Implications for antiangiogenic activity in hepatocellular
carcinoma. Clin Cancer Res. 18:5662–5671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gonçalves A, Monges G, Yang Y, Palmerini
F, Dubreuil P, Noguchi T, Jacquemier J, Di Stefano D, Delpero JR,
Sobol H and Bertucci F: Response of a KIT-positive Extra-abdominal
fibromatosis to imatinib mesylate and KIT genetic analysis. J Natl
Cancer Inst. 98:562–563. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kim S, Yazici YD, Calzada G, Wang ZY,
Younes MN, Jasser SA, El-Naggar AK and Myers JN: Sorafenib inhibits
the angiogenesis and growth of orthotopic anaplastic thyroid
carcinoma xenografts in nude mice. Mol Cancer Ther. 6:1785–1792.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu L, Cao Y, Chen C, Zhang X, McNabola A,
Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the
RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor
cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer
Res. 66:11851–11858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mace J, Biermann JS, Sondak V, McGinn C,
Hayes C, Thomas D and Baker L: Response of extraabdominal desmoid
tumors to therapy with imatinib mesylate. Cancer. 95:2373–2379.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cho NL, Carothers AM, Rizvi H, Hasson RM,
Redston M and Bertagnolli MM: Immunohistochemical and molecular
analysis of tyrosine kinase activity in? desmoid tumors. J Surg
Res. 173:0–326. 2012. View Article : Google Scholar
|
|
67
|
Skubitz KM, Manivel JC, Clohisy DR and
Frolich JW: Response of imatinib-resistant extra-abdominal
aggressive fibromatosis to sunitinib: Case report and review of the
literature on response to tyrosine kinase inhibitors. Cancer
Chemother Pharmacol. 64:635–640. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jo JC, Hong YS, Kim KP, Lee JL, Lee J,
Park YS, Kim SY, Ryu JS, Lee JS and Kim TW: A prospective
multicenter phase II study of sunitinib in patients with advanced
aggressive fibromatosis. Invest New Drugs. 32:369–376. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Gounder MM, Lefkowitz RA, Keohan ML,
D'Adamo DR, Hameed M, Antonescu CR, Singer S, Stout K, Ahn L and
Maki RG: Activity of sorafenib against desmoid Tumor/Deep
fibromatosis. Clin Cancer Res. 17:4082–4090. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Braggio D, Koller D, Jin F, Siva N, Zewdu
A, Lopez G, Batte K, Casadei L, Welliver M, Strohecker AM, et al:
Autophagy inhibition overcomes sorafenib resistance in S45F-mutated
desmoid tumors. Cancer. 125:2693–2703. 2019.PubMed/NCBI
|
|
71
|
Shimizu K, Hamada S, Sakai T, Koike H,
Yoshida M and Nishida Y: Efficacy of low-dose chemotherapy with
methotrexate and vinblastine for patients with extra-abdominal
desmoid-type fibromatosis: A systematic review. Jpn J Clin Oncol.
50:419–424. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Skapek SX, Ferguson WS, Granowetter L,
Devidas M, Perez-Atayde AR, Dehner LP, Hoffer FA, Speights R,
Gebhardt MC, Dahl GV, et al: Vinblastine and methotrexate for
desmoid fibromatosis in children: Results of a pediatric oncology
group phase II trial. J Clin Oncol. 25:501–506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Azzarelli A, Gronchi A, Bertulli R, Tesoro
JD, Baratti D, Pennacchioli E, Dileo P, Rasponi A, Ferrari A,
Pilotti S and Casali PG: Low-dose chemotherapy with methotrexate
and vinblastine for patients with advanced aggressive fibromatosis.
Cancer. 92:1259–1264. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Reich S, Overberg-Schmidt US, Bührer C and
Henze G: Low-dose chemotherapy with vinblastine and methotrexate in
childhood desmoid tumors. J Clin Oncol. 17:10861999. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Meazza C, Bisogno G, Gronchi A, Fiore M,
Cecchetto G, Alaggio R, Milano GM, Casanova M, Carli M and Ferrari
A: Aggressive fibromatosis in children and adolescents: The Italian
experience. Cancer. 116:233–240. 2010.PubMed/NCBI
|
|
76
|
Ananth P, Werger A, Voss S,
Rodriguez-Galindo C and Janeway KA: Liposomal doxorubicin:
Effective treatment for pediatric desmoid fibromatosis. Pediatr
Blood Cancer. Dec 1–2017.(Epub ahead of print). doi:
10.1002/pbc.26375. View Article : Google Scholar
|
|
77
|
Weiss AJ, Horowitz S, Lackman RD and
Lackmen RD: Therapy of desmoid tumors and fibromatosis using
vinorelbine. Am J Clin Oncol. 22:193–195. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Gronchi A, Colombo C, Le Péchoux C, Dei
Tos AP, Le Cesne A, Marrari A, Penel N, Grignani G, Blay JY, Casali
PG, et al: Sporadic desmoid-type fibromatosis: A stepwise approach
to a non-metastasising neoplasm-a position paper from the Italian
and the French Sarcoma Group. Ann Oncol. 25:578–583. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
van Dalen EC, Michiels EM, Caron HN and
Kremer LC: Different anthracycline derivates for reducing
cardiotoxicity in cancer patients. Cochrane Database Syst Rev.
4:CD0050062006.
|
|
80
|
Wehl G, Rossler J, Otten JE, Boehm N, Uhl
M, Kontny U and Niemeyer C: Response of progressive fibromatosis to
therapy with liposomal doxorubicin. Onkologie. 27:552–556.
2004.PubMed/NCBI
|
|
81
|
Constantinidou A, Jones RL, Scurr M,
Al-Muderis O and Judson I: Pegylated liposomal doxorubicin, an
effective, well-tolerated treatment for refractory aggressive
fibromatosis. Eur J Cancer. 45:2930–2934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shkalim Zemer V, Toledano H, Kornreich L,
Freud E, Atar E, Avigad S, Feinberg-Gorenshtein G, Fichman S,
Issakov J, Dujovny T, et al: Sporadic desmoid tumors in the
pediatric population: A single center experience and review of the
literature. J Pediatr Surg. 52:1637–1641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ayala AG, Ro JY, Goepfert H, Cangir A,
Khorsand J and Flake G: Desmoid fibromatosis: A clinicopathologic
study of 25 children. Semin Diagn Pathol. 3:138–150.
1986.PubMed/NCBI
|
|
84
|
Bonvalot S, Rimareix F, Causeret S, Le
Péchoux C, Boulet B, Terrier P, Le Cesne A and Muret J:
Hyperthermic isolated limb perfusion in locally advanced soft
tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1
mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol.
16:3350–3357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
van Broekhoven DL, Deroose JP, Bonvalot S,
Gronchi A, Grünhagen DJ, Eggermont AM and Verhoef C: Isolated limb
perfusion using tumour necrosis factor α and melphalan in patients
with advanced aggressive fibromatosis. Br J Surg. 101:1674–1680.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Raney B, Evans A, Granowetter L, Schnaufer
L and Littman P: Nonsurgical management of children with recurrent
OT unresectable fibromatosis. Pediatrics. 79:394–398.
1987.PubMed/NCBI
|
|
87
|
Weiss AJ and Lackman RD: Low-dose
chemotherapy of desmoid tumors. Cancer. 64:1192–1194. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cole NM: Extra-abdominal desmoid tumors. J
Bone Joint Surg Br. 53:373–377. 1979.
|
|
89
|
Raney RB J: Chemotherapy for children with
aggressive fibromatosis and Langerhans' cell histiocytosis. Clin
Orthop Relat Res. 58–63. 1991.PubMed/NCBI
|
|
90
|
Kummar S, O'Sullivan Coyne G, Do KT,
Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R,
Horneffer Y, et al: Clinical Activity of the γ-Secretase inhibitor
PF-03084014 in adults with desmoid tumors (Aggressive
Fibromatosis). J Clin Oncol. 35:1561–1569. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Agresta L, Kim H, Turpin BK, Nagarajan R,
Plemmons A, Szabo S, Dasgupta R, Sorger JI and Pressey JG:
Pazopanib therapy for desmoid tumors in adolescent and young adult
patients. Pediatr Blood Cancer. 65:e269682018. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Rombouts SJE, Vogel JA, Van Santvoort HC,
van Lienden KP, van Hillegersberg R, Busch OR, Besselink MG and
Molenaar IQ: Systematic review of innovative ablative therapies for
the treatment of locally advanced pancreatic cancer. Br J Surg.
102:182–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhou Y: High-Intensity focused ultrasound
treatment for advanced pancreatic Cancer. Gastroenterol Res Pract.
2014:2053252014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Grimaldi MC, Trentin C, Gullo RL and
Cassano E: Fibromatosis of the breast mimicking cancer: A case
report. Radiol Case Rep. 13:1–5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Haar GT and Coussios C: High intensity
focused ultrasound: Past, present and future. Int J Hyperthermia.
23:85–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Ghanouni P, Dobrotwir A, Bazzocchi A,
Bucknor M, Bitton R, Rosenberg J, Telischak K, Busacca M, Ferrari
S, Albisinni U, et al: Magnetic resonance-guided focused ultrasound
treatment of extra-abdominal desmoid tumors: A retrospective
multicenter study. Eur Radiol. 27:732–740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Shi Y, Huang Y, Zhou M, Ying X and Hu X:
High-intensity focused ultrasound treatment for intra-abdominal
desmoid tumors: A report of four cases. J Med Ultrasonics.
43:279–284. 2016. View Article : Google Scholar
|
|
98
|
Wang Y, Wang W and Tang J:
Ultrasound-guided high intensity focused ultrasound treatment for
extra-abdominal desmoid tumours: Preliminary results. Int J
Hyperthermia. 27:648–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhao WP, Han ZY, Zhang J, Yu XL, Cheng ZG,
Zhou X and Liang P: Early experience: High-intensity focused
ultrasound treatment for intra-abdominal aggressive fibromatosis of
failure in surgery. Br J Radiol. 89:201510262016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Kurup AN and Callstrom MR: Image-guided
percutaneous ablation of bone and soft tissue tumors. Semin
Intervent Radiol. 27:276–284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kurup AN and Callstrom MR: Expanding role
of percutaneous ablative and consolidative treatments for
musculoskeletal tumours. Clin Radiol. 72:645–656. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Schmitz JJ, Schmit GD, Atwell TD,
Callstrom MR, Kurup AN, Weisbrod AJ and Morris JM: Percutaneous
cryoablation of extraabdominal desmoid tumors: A 10-year
experience. Am J Roentgenol. 207:190–195. 2016. View Article : Google Scholar
|
|
103
|
Havez M, Lippa N, Al-Ammari S, Kind M and
Cornelis F: Percutaneous image-guided cryoablation in inoperable
extra-abdominal desmoid tumors: A study of tolerability and
efficacy. Cardiovasc Intervent Radiol. 37:1500–1506. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Baek JH, Lee JH, Jin YS, Bae JI and Na DG:
Complications encountered in the treatment of benign thyroid
nodules with US-guided radiofrequency ablation: A multicenter
study. Radiology. 262:335–342. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Kim AH, Ko HK, Won JY and Lee DY:
Percutaneous radiofrequency ablation: A novel treatment of facial
venous malformation. J Vasc Surg. 50:424–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Barrow E, Newton K, Rajashanker B, Lee S,
Evans DG and Hill J: Successful radiofrequency ablation of an
anterior abdominal wall desmoid in familial adenomatous polyposis.
Colorectal Dis. 15:e160–e163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ilaslan H, Schils J, Joyce M, Marks K and
Sundaram M: Radiofrequency ablation: Another treatment option for
local control of desmoid tumors. Skeletal Radiol. 39:169–173. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Tsz-Kan T, Man-Kwong C, Shang-Jen JS,
Ying-Lee L, Wai Man-Wah A and Hon-Shing F: Radiofrequency ablation
of recurrent fibromatosis. J Vasc Int Radiol. 18:147–150. 2007.
View Article : Google Scholar
|
|
109
|
Ko HK and Kang HG: Radiofrequency ablation
for the treatment of recurring desmoid tumors after repeated
surgical resection: Usefulness of the moving-tip technique. Curr
Orthop Pract. 24:547–551. 2013. View Article : Google Scholar
|
|
110
|
Eastley NC, Hennig IM, Esler CP and
Ashford RU: Nationwide trends in the current management of desmoid
(Aggressive) fibromatosis. Clin Oncol. 27:362–368. 2015. View Article : Google Scholar
|
|
111
|
de Camargo VP, Keohan ML, D'Adamo DR,
Antonescu CR, Brennan MF, Singer S, Ahn LS and Maki RG: Clinical
outcomes of systemic therapy for patients with deep fibromatosis
(desmoid tumor). Cancer. 116:2258–2265. 2010.PubMed/NCBI
|
|
112
|
Tanaka K, Yoshikawa R, Yanagi H, Gega M,
Fujiwara Y, Hashimoto-Tamaoki T, Hirota S, Tsujimura T and Tomita
N: Regression of sporadic intra-abdominal desmoid tumour following
administration of non-steroidal anti-inflammatory drug. World J
Surg Oncol. 6:172008. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Sturt NJH, Phillips RK and Clark SK:
High-dose tamoxifen and sulindac as first-line treatment for
desmoid tumors. Cancer. 101:6522004. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lackner H, Urban C, Kerbl R, Schwinger W
and Beham A: Noncytotoxic drug therapy in children with
unresectable desmoid tumors. Cancer. 80:334–340. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bocale D, Rotelli MT, Cavallini A and
Altomare DF: Anti-oestrogen therapy in the treatment of desmoid
tumours: A systematic review. Colorectal Dis. 13:e388–e395. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Okuno S: The enigma of desmoid tumors.
Curr Treat Options Oncol. 7:438–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Yaffe K, Krueger K, Sarkar S, Grady D,
Barrett-Connor E, Cox DA and Nickelsen T; Multiple Outcomes of
Raloxifene Evaluation Investigators, : Cognitive function in
postmenopausal women treated with raloxifene. N Engl J Med.
344:1207–1213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ettinger B, Black DM, Mitlak BH,
Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas
PD, Zanchetta JR, Stakkestad J, et al: Reduction of vertebral
fracture risk in postmenopausal women with osteoporosis treated
with raloxifene: Results from a 3-year randomized clinical trial.
Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA. 282:637–645. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Cummings SR, Eckert S, Krueger KA, Grady
D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH,
Morrow M, et al: The effect of raloxifene on risk of breast cancer
in postmenopausal Women: Results From the MORE randomized trial.
Multiple Outcomes of Raloxifene Evaluation. JAMA. 281:2189–2197.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Delmas PD, Bjarnason NH, Mitlak BH, Ravoux
AC, Shah AS, Huster WJ, Draper M and Christiansen C: Effects of
raloxifene on bone mineral density, serum cholesterol
concentrations, and uterine endometrium in postmenopausal women. N
Engl J Med. 337:1641–1647. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Desurmont T, Lefèvre JH, Shields C, Colas
C, Tiret E and Parc Y: Desmoid tumour in familial adenomatous
polyposis patients: Responses to treatments. Fam Cancer. 14:31–39.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Quast DR, Schneider R, Burdzik E, Hoppe S
and Möeslein G: Long-term outcome of sporadic and FAP-associated
desmoid tumors treated with high-dose selective estrogen receptor
modulators and sulindac: A single-center long-term observational
study in 134 patients. Fam Cancer. 15:31–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Bauernhofer T, Stöger H, Schmid M, Smola
M, Gürtl-Lackner B, Höfler G, Ranner G, Reisinger E and Samonigg H:
Sequential treatment of recurrent mesenteric desmoid tumor. Cancer.
77:1061–1065. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Skapek SX, Anderson JR, Hill DA, Henry D,
Spunt SL, Meyer W, Kao S, Hoffer FA, Grier HE, Hawkins DS and Raney
RB: Safety and efficacy of high-dose tamoxifen and sulindac for
desmoid tumor in children: Results of a Children's Oncology Group
(COG) phase II study. Pediatr Blood Cancer. 60:1108–1112. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wang Z, Wu J, Tian X and Hao C: Targeted
therapy of desmoid-type fibromatosis: Mechanism, current situation,
and future prospects. Front Med. 13:427–437. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Tsukada K, Church JM, Jagelman DG, Fazio
VW, McGannon E, George CR, Schroeder T, Lavery I and Oakley J:
Noncytotoxic drug therapy for intra-abdominal desmoid tumor in
patients with familial adenomatous polyposis. Dis Colon Rectum.
35:29–33. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Huang PW and Tzen CY: Prognostic factors
in desmoid-type fibromatosis. Pathology. 42:147–150. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Nishida Y, Tsukushi S, Shido Y, Urakawa H,
Arai E and Ishiguro N: Transition of treatment for patients with
extra-abdominal desmoid tumors: Nagoya University modality.
Cancers. 4:88–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Yang S, Wang X, Jiang H, Wang Y, Li Z and
Lu H: Effective treatment of aggressive fibromatosis with celecoxib
guided by genetic testing. Cancer Biol Ther. 18:757–760. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Wang YC and Wong JU: Complete remission of
pancreatic head desmoid tumor treated by COX-2 inhibitor-a case
report. World J Surg Oncol. 14:1902016. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Waddell W: Indomethacin and ascorbate
inhibit desmoid tumors. J Surg Oncol. 15:85–90. 2010. View Article : Google Scholar
|
|
132
|
Yildiz F, Kars A, Cengiz M, Yildiz O,
Akyürek S, Selek U, Ozyigit G and Atahan IL: 1,25-Dihydroxy vitamin
D3: Can it be an effective therapeutic option for aggressive
fibromatosis. Med Hypotheses. 64:333–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Ferah Y, Ayse K, Mustafa C, Ugur S, Murat
G and Lale AI: Possible therapeutic role of vitamin D-3 in
aggressive fibromatosis. Jpn J Clin Oncol. 34:472–475. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Leithner A, Schnack B, Katterschafka T,
Wiltschke C, Amann G, Windhager R, Kotz R and Zielinski CC:
Treatment of extra-abdominal desmoid tumors with interferon-alpha
with or without tretinoin. J Surg Oncol. 73:21–25. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Goto T, Nemoto T, Ogura K, Hozumi T and
Funata N: Successful treatment of desmoid tumor of the chest wall
with tranilast: A case report. J Med Case Rep. 4:3842010.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Nakada I, Ubukata H, Goto Y, Watanabe Y,
Sato S, Tabuchi T and Soma T: Prednisolone therapy for
intra-abdominal desmoid tumors in a patient with familial
adenomatous polyposis. J Gastroenterol. 32:255–259. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Umemoto S, Makuuchi H, Amemiya T,
Yamaguchi H, Oka S, Owada T and Koizumi K: Intra-abdominal desmoid
tumors in familial polyposis coli: A case report of tumor
regression by prednisolone therapy. Dis Colon Rectum. 34:89–93.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Waddell WR, Cerner RE and Reich MP:
Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors
and carcinoma of the stomach. J Surg Oncol. 22:197–211. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Waddell DWR and Gerner RE: Indomethacin
and ascorbate inhibit desmoid tumors. J Surg Oncol. 15:85–90. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Crago AM, Denton B, Salas S, Dufresne A,
Mezhir JJ, Hameed M, Gonen M, Singer S and Brennan MF: A prognostic
nomogram for prediction of recurrence in desmoid fibromatosis. Ann
Surg. 258:347–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Faulkner L: Pediatric desmoid tumor:
Retrospective analysis of 63 cases. J Clin Oncol. 13:2813–2818.
1995. View Article : Google Scholar : PubMed/NCBI
|
